Oncolytics Biotech (ONCY) Tops Q2 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• T-Mobile to Host Q3 2026 Earnings Call on October 28, 2026
• Goldman sees India AI infrastructure stocks up 60% in 2026